Freeport-McMoRan Inc vs GeneDx Holdings Corp — how do they compare? Freeport-McMoRan Inc trades at $69.67 (market cap $96.42B), while GeneDx Holdings Corp trades at $82 (market cap $2.44B). The key difference: Freeport-McMoRan Inc is far larger — about 39.5× GeneDx Holdings Corp's market cap, and Freeport-McMoRan Inc pays a 0.87% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| FCX | WGS | |
|---|---|---|
Market Cap | $96.42B | $2.44B |
Sector | Basic Materials | Technology |
52-Week High | $71.73 | $167.51 |
52-Week Low | $35.34 | $34.51 |
Enterprise Value | $102.70B | $2.48B |
Dividend Yield | 0.87% | — |
Trailing returns across standard periods
Latest headlines on both assets
Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia
Read more on FCX →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →